This Infectious Disease Point-of-care Diagnostics Market research report contains intricate details to help identify the right parameters and provide valuable information. The report provides an in-depth analysis of the business sector, including factors such as market size, competitive landscape, growth trends, product utilization, growth prospects by region, application potential, and so on.
This report on Infectious Disease Point-of-care Diagnostics Market provides a comprehensive analysis of consumer behavior, brand positioning, pricing analysis, and key player strategies. A market overview is provided in the research report based on inputs from industry analysts, prominent players, trade associations, and industrial groups.
Click Here to Access Free sample PDF Copy of the Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/104307
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future.
The global infectious disease point-of-care diagnostics market size was USD 1.12 billion in 2020.The market is projected to grow from USD 1.3 billion in 2021 to USD 3.96 billion in 2028 at a CAGR of 17.2% in the 2021-2028 period. The sudden rise in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.
Key players covered in the global Infectious Disease Point-of-care Diagnostics Market research report:
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
- Abbott Laboratories (Illinois, U.S)
- Quest Diagnostics Incorporated (New Jersey, United States)
- BD (Franklin Lakes, U.S)
- bioMérieux SA (Marcy l'Etoile, France)
- Cardinal Health, Inc. (Ohio, U.S)
- Mesa Biotech (California, U.S)
- Cepheid (California, U.S)
- Trinity Biotech (Bray, Ireland)
- Quidel Corporation (San Diego, U.S.)
- Bio-Rad Laboratories Inc. (California, U.S)
- Other Players
Drivers & Restraints
Globally, the increasing prevalence of HIV/Influenza/RSV, etc., leads to an increase in the rate of diagnosis of patients. For instance, according to the United Nations Program on HIV/AIDS (UNAIDS), in 2019, approximately 38 million people were diagnosed with HIV/AIDS. Furthermore, according to another report published by the World Health Organization (WHO), in the year 2018, around 10 million people were affected by tuberculosis worldwide. Thus, the growing infection rate of the various diseases globally will lead to an increase in the uptake of infectious disease point of care products for its diagnosis and subsequently aid the growth of the market during the forecast period.
Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses of infectious disease resulted in inaccurate results and were time-consuming. This flaw led to the emergence of rapid, accurate, and portable point-of-care testing products in the market.POC testing enables faster diagnosis of infectious disease near the patient site providing quick results. Several researchers are now focused on the development of multiplex point-of-care diagnostic technologies.
Quick Buy - Infectious Disease Point-of-care Diagnostics Market :
https://www.fortunebusinessinsights.com/checkout-page/104307
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
KEY BENEFITS
- This report provides an extensive analysis of the current & emerging market trends and dynamics in the Infectious Disease Point-of-care Diagnostics Market.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
- The report offers the current state of the market and future prospects for various geographical regions.
- It provides an in-depth analysis of the market, highlighting its growth rates and opportunities for growth.
Major Points from Table of Contents:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments - Merger, Acquisitions, and Partnerships
- Porter’s Five Forces Analysis
- SWOT Analysis
- Technological Developments
- Value Chain Analysis
Continued…
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Caused sudden and drastic downturn in economic activity
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
The global “infectious disease point of care diagnostics market” size is projected to reach USD 3,371.1 million by the end of 2027.
The presence of several large-scale companies in this sector will emerge in favor of market growth.
According to a report published by Fortune Business Insights, titled “Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test, Molecular Diagnostics, and Others), By Disease (HIV, Hepatitis B Virus, Pneumonia/Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV), Influenza, Clostridium Difficile Infections (CDI), Hepatitis C Virus, Methicillin Resistant Staphylococcus Aureus (MRSA), Tuberculosis, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home & Self-Testing, Nursing Homes, and Others), and Regional Forecast, 2020-2027” the market was worth USD 1246.5 million and will exhibit a CAGR of 17.4% during the forecast period, 2020-2027.Point of care (PoC) testing allows faster diagnosis of diseases at the patient site itself.
The drawbacks of conventional diagnostic methods including time to test, inefficiency, and non-portability can be overcome through infectious disease PoC diagnosis.
Recent technological advances have opened up a massive potential for the growth of the market in the past few years.
Additionally, increasing research activities will also emerge in favor of market growth in the forthcoming years.Major Infectious Disease Point of Care Diagnostics Market Key players covered in the report include:Hoffmann-La Roche Ltd (Basel, Switzerland)Thermo Fisher Scientific Inc. (Massachusetts, U.S.)Abbott Laboratories (Illinois, U.S)Quest Diagnostics Incorporated (New Jersey, United States)BD (Franklin Lakes, U.S)bioMérieux SA (Marcy l'Etoile, France)Cardinal Health, Inc. (Ohio, U.S)Mesa Biotech (California, U.S)Cepheid (California, U.S)Trinity Biotech (Bray, Ireland)Quidel Corporation (San Diego, U.S.)Bio-Rad Laboratories Inc. (California, U.S)Other PlayersGet Request a Sample Copy of the Infectious Disease Point of Care Diagnostics Report:https://www.fortunebusinessinsights.com/enquiry/sample/infectious-disease-point-of-care-poc-diagnostics-market-104307Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches.
